Selection of Retapamulin, a Novel Pleuromutilin for Topical Use

Stephen Rittenhouse, Sanjoy Kanti Biswas, John P. Broskey, Lynn McCloskey, Terrance Moore, Sandra Y. Vasey, Joshua M. West, Magdalena Zalacaín, Rimma Zonis, David Payne

Antimicrobial Agents and Chemotherapy · 2006 · 91 citations · 5 references

DOIFull text

Open access

Concepts

Abstract

The in vitro activity of retapamulin was determined and compared to that of topical and community antibiotics. The MIC(90)s of retapamulin against Staphylococcus aureus and Streptococcus pyogenes were 0.12 microg/ml and 0.016 microg/ml, respectively. Retapamulin has a low propensity to select resistance and produces an in vitro postantibiotic effect.

References

5